Global RNAi Technology Market Projected to Reach $1.9 Billion by 2028: Precision Medicine Integration Accelerating Personalized Treatments

Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technology Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to's offering.

The Global RNAi Technology Market, a vital player in the biotechnology and pharmaceutical industries, is set to exhibit robust growth with a projected CAGR of 9.89% from 2022 through 2028, reaching USD 1.9 billion. At the forefront of genetic regulation and therapeutic innovation, RNAi technology has become a bedrock for advancements in gene therapy, functional genomics, and personalized medicine.

The Market's Growth Trajectory

Expanding on a value of USD 1.08 billion in 2022, the market's upward trajectory is powered by growing demand for RNAi-based therapeutics and the rise of chronic diseases globally. RNAi technology's precision in gene silencing opens up a host of possibilities for treatment modalities, especially in cancer, viral infections, and genetic disorders.

The escalating incidence of chronic illnesses, coupled with an aging population and lifestyle changes, accentuates the urgency for revolutionary treatment options, which RNAi technology is poised to deliver. Its capacity for gene-specific interventions pioneers the approach to personalized medicine, where therapeutics are customized to individual gene profiles.

Key Market Drivers and Challenges

Rigorous approval protocols and intellectual property rights remain critical for navigating the market landscape, along with fierce competition and relentless technological evolution. Notwithstanding its promising future, challenges like the risk of off-target effects and immune responses loom large, calling for innovative solutions and rigorous testing to maintain patient safety and therapeutic efficacy.

Trends Shaping the Future of RNAi Technology

  • Advancements in RNAi delivery systems, such as lipid nanoparticles (LNPs) and viral vectors, are catalyzing a new wave of therapeutics, enhancing target specificity and minimizing side effects.
  • RNAi's integration with precision medicine signals the emergence of next-generation personalized therapies, profoundly impacting drug discovery and treatment strategies.
  • Functional genomics research benefits extensively from RNAi, streamlining drug target validation and compound screening processes, ultimately expediting novel drug development.

Breaking New Ground in Various Sectors

With a focus on applications ranging from therapeutics to agriculture, the RNAi Technology Market is bridging critical gaps in healthcare and crop protection. The technology's adaptability and precision herald a new era of sustainable agricultural practices and targeted medical interventions.

Regional Market Insights

In the global arena, North America has taken the lead, powered by robust infrastructure, significant R&D investments, and a strong regulatory framework. This regional dominance reflects the coordinated efforts of the biotech and pharmaceutical industries in capitalizing on RNAi's transformative potential.

Segmental Insights and Competitive Landscape

The RNAi Technology Market features several segments, including type, application, end-user, and region. Small interfering RNA (siRNA) spearheads the type segment, with therapeutic applications asserting dominance due to their significant impact on chronic disease management.

A competitive analysis of major players underscores a landscape marked by strategic collaborations and relentless pursuit of innovation, ensuring the market's dynamic and responsive growth. A selection of companies mentioned in this report includes:

  • Alnylam Pharmaceuticals, Inc
  • Ionis Pharmaceuticals, Inc
  • Atalanta Therapeutics
  • Phio Pharmaceuticals
  • Benitec Biopharma
  • Novartis AG
  • AstraZeneca
  • Silence Therapeutics
  • Arbutus Biopharma
  • Sylentis SA

Key Attributes

Report AttributeDetails
No. of Pages190
Forecast Period2022-2028
Estimated Market Value (USD) in 2022$1.08 Billion
Forecasted Market Value (USD) by 2028$1.9 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.